Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

The 45-year-old is back on trial after a jury in 2024 was unable to agree on whether she was guilty or not. The case hinges on the question of whether Read hit O’Keefe, 46, in a drunken rage or ...